Pricing Log in Create free account

Enovis Corporation (ENOV) vs PROCEPT BioRobotics Corporation (PRCT)

Enovis Corporation and PROCEPT BioRobotics Corporation are both Medical Devices companies. Enovis Corporation is the larger, with a market value of $1.7B against $1.2B — 1.4× the size. PROCEPT BioRobotics Corporation grew revenue faster over the last twelve months: 17.5% against 3.28%. Enovis Corporation has the higher net margin (−22.9% vs −32.6%) and the higher return on invested capital (−10.8% vs −45.6%). Across the 18 metrics below, Enovis Corporation leads on 10 and PROCEPT BioRobotics Corporation on 8.

Valuation

Metric ENOV PRCT Medical Devices median
P/E n/m n/m 25.58
P/S 0.72 3.27 2.54
P/B 1.11 3.51 2.48
Price to free cash flow 23.80 n/m 28.81
EV/EBITDA 9.39 n/m 11.51
EV/Sales 1.26 2.81 2.72
Earnings yield (32.54%) (10.04%) (12.82%)
Free cash flow yield 4.20% (7.38%) (8.18%)

Profitability

Metric ENOV PRCT Medical Devices median
Gross margin 61.31% 64.66% 57.76%
Operating margin (20.59%) (33.61%) (15.07%)
Net margin (22.87%) (32.60%) (14.45%)
Free cash flow margin 3.02% (24.15%) (3.88%)
Return on equity (29.97%) (32.39%) (10.35%)
Return on assets (12.91%) (23.31%) (17.26%)
Return on invested capital (10.83%) (45.60%) (5.27%)

Growth

Metric ENOV PRCT Medical Devices median
Revenue growth (TTM) 3.28% 17.47% 10.41%
EPS growth (last fiscal year) (38.98%) 1.71% 28.17%
Revenue growth, 5-year CAGR 14.94% 109.04% 15.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ENOV PRCT Medical Devices median
Debt to equity 0.84 0.16 0.04
Current ratio 2.15 5.89 2.74
Net debt to EBITDA 5.73 2.41 0.54

Dividend

Metric ENOV PRCT Medical Devices median
Dividend yield — — 1.02%
Payout ratio — — 0.37

Size

Metric ENOV PRCT Medical Devices median
Market cap 1.65b 1.16b 239.53m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack